News
FDA Suspends U.S. License of Chikungunya Vaccine
By Stephanie Brown HealthDay ReporterMONDAY, Aug. 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is suspending the biologics license for the live-attenuated chikungunya vaccine, Ixchiq, in the United States. The move comes after reports of serious side effects in older adults similar to the symptoms of chikungunya virus.
FDA suspends license for chikungunya vaccine Ixchiq over serious safety concerns
The US Food and Drug Administration (FDA) announced late last week that it has suspended the license for French drugmaker Valneva's chikungunya vaccine, saying that continued administration of the vaccine to the public would pose a danger to health.
Mosquito-borne chikungunya virus has caused an outbreak in China, but public health experts say the risk for spread and ...
DEAR DR. ROACH: I have a friend who lives in Paraguay and had been diagnosed with chikungunya. It has been extremely painful ...
The U.S. Centers for Disease Control and Prevention has issued a travel warning following an outbreak of a mosquito-borne ...
Dear J.: Chikungunya may not sound like a real medical condition, but it is a viral disease that was first found in West ...
The war against the chikungunya virus that claims lives, which is dominant along the country’s coastal towns, has suffered a ...
There have been 33 locally-transmitted cases of the tropical disease in a neighborhood in the city of Vitrolles in the south ...
Chikungunya, a mosquito-borne viral infection, is witnessing a surge in reported cases across several regions, raising public ...
Interesting Engineering on MSN5d
World Mosquito Day: Once rare, chikungunya now spreads at record global pace
Within this global backdrop, Europe is seeing consequential shifts. The mosquito that can spread the chikungunya virus, Aedes ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback